Delivery Order SPE2DB22D3016-SPE2DB24FANY7
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,240.98 firm fixed price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,292.38, is for the delivery of ABRAXANE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of December 19, 2023 and is a firm fixed price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the provision of ABRAXANE 100 MG VIALS. The contract has a potential value of $8,837.51 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,140.40, is for the delivery of ABRAXANE 100 MG VIALS. This is a Firm Fixed Price Delivery Order contract, with a performance period running through April 10, 2024. The contract did not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563188797 ABRAXANE 100 MG VIALS. The order, valued at $16,981.70, has a completion date of December 28, 2023. Amerisourcebergen Drug Corp, a for-profit organization, provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order is part of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ABRAXANE 100 MG VIALS. The contract has a ceiling value of $35,702.00 and runs through September 28, 2023. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,294.87, is a Firm Fixed Price Delivery Order for the supply of ABRAXANE 100 MG VIALS, a specialty oncology medication. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 mg vials of the specialty pharmaceutical ABRAXANE. The contract has a ceiling value of $2,856.16 and a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not part of a set-aside program. Amerisourcebergen Drug Corp also holds an indefinite delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of ABRAXANE 100 MG VIALS, a pharmaceutical product, with a ceiling value of $4,833.48 and a completion date of April 30, 2024. AmerisourceBergen Drug Corporation is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- The Defense Logistics Agency awarded a delivery order valued at $16,261.46 to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with an ultimate completion date of November 21, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger contract vehicle with the DLA. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location, which serves as the...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FANY7Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The contract is a firm fixed price delivery order with a potential value of $3,943.32 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp has received numerous prior awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. This order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 3/4/24 |